Noce, Marcella Paino, Francesca Mele, Luigi Papaccio, Gianpaolo Regad, Tarik Lombardi, Angela Papaccio, Federica Desiderio, Vincenzo Tirino, Virginia Additional file 4: of HDAC2 depletion promotes osteosarcoma’s stemness both in vitro and in vivo: a study on a putative new target for CSCs directed therapy Figure S2. Evaluation of CD133 marker on Saos2 and MG63 cell lines after VPA and DAC treatment. Flow cytometric analyses showed a strong increase of CD133 expression after drug treatments. ** p < 0.001, *** p < 0.0001 compared to the untreated cells. (TIF 242 kb) Cancer stem cells;Osteosarcomas;Methylation;HDAC2;DNMT3a 2018-12-03
    https://springernature.figshare.com/articles/figure/Additional_file_4_of_HDAC2_depletion_promotes_osteosarcoma_s_stemness_both_in_vitro_and_in_vivo_a_study_on_a_putative_new_target_for_CSCs_directed_therapy/7414907
10.6084/m9.figshare.7414907.v1